Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2011 May 27;28621:18562-72. doi: 10.1074/jbc.M110.184101.
Show Gene links
Show Anatomy links
FXYD proteins reverse inhibition of the Na+-K+ pump mediated by glutathionylation of its beta1 subunit.
Bibert S
,
Liu CC
,
Figtree GA
,
Garcia A
,
Hamilton EJ
,
Marassi FM
,
Sweadner KJ
,
Cornelius F
,
Geering K
,
Rasmussen HH
.
???displayArticle.abstract???
The seven members of the FXYD protein family associate with the Na(+)-K(+) pump and modulate its activity. We investigated whether conserved cysteines in FXYD proteins are susceptible to glutathionylation and whether such reactivity affects Na(+)-K(+) pump function in cardiac myocytes and Xenopus oocytes. Glutathionylation was detected by immunoblotting streptavidin precipitate from biotin-GSH loaded cells or by a GSH antibody. Incubation of myocytes with recombinant FXYD proteins resulted in competitive displacement of native FXYD1. Myocyte and Xenopus oocyte pump currents were measured with whole-cell and two-electrode voltage clamp techniques, respectively. Native FXYD1 in myocytes and FXYD1 expressed in oocytes were susceptible to glutathionylation. Mutagenesis identified the specific cysteine in the cytoplasmic terminal that was reactive. Its reactivity was dependent on flanking basic amino acids. We have reported that Na(+)-K(+) pump β(1) subunit glutathionylation induced by oxidative signals causes pump inhibition in a previous study. In the present study, we found that β(1) subunit glutathionylation and pump inhibition could be reversed by exposing myocytes to exogenous wild-type FXYD3. A cysteine-free FXYD3 derivative had no effect. Similar results were obtained with wild-type and mutant FXYD proteins expressed in oocytes. Glutathionylation of the β(1) subunit was increased in myocardium from FXYD1(-/-) mice. In conclusion, there is a dependence of Na(+)-K(+) pump regulation on reactivity of two specifically identified cysteines on separate components of the multimeric Na(+)-K(+) pump complex. By facilitating deglutathionylation of the β(1) subunit, FXYD proteins reverse oxidative inhibition of the Na(+)-K(+) pump and play a dynamic role in its regulation.
Arimochi,
Interaction of Mat-8 (FXYD-3) with Na+/K+-ATPase in colorectal cancer cells.
2007, Pubmed
Arimochi,
Interaction of Mat-8 (FXYD-3) with Na+/K+-ATPase in colorectal cancer cells.
2007,
Pubmed
Bibert,
Phosphorylation of phospholemman (FXYD1) by protein kinases A and C modulates distinct Na,K-ATPase isozymes.
2008,
Pubmed
,
Xenbase
Bossuyt,
Expression and phosphorylation of the na-pump regulatory subunit phospholemman in heart failure.
2005,
Pubmed
Bundgaard,
β(3) adrenergic stimulation of the cardiac Na+-K+ pump by reversal of an inhibitory oxidative modification.
2010,
Pubmed
Cornelius,
Functional modulation of the sodium pump: the regulatory proteins "Fixit".
2003,
Pubmed
Cornelius,
Functional significance of the shark Na,K-ATPase N-terminal domain. Is the structurally variable N-Terminus involved in tissue-specific regulation by FXYD proteins?
2005,
Pubmed
Crambert,
Phospholemman (FXYD1) associates with Na,K-ATPase and regulates its transport properties.
2002,
Pubmed
,
Xenbase
Dalle-Donne,
Molecular mechanisms and potential clinical significance of S-glutathionylation.
2008,
Pubmed
Dempski,
Fluorometric measurements of intermolecular distances between the alpha- and beta-subunits of the Na+/K+-ATPase.
2006,
Pubmed
,
Xenbase
Figtree,
Reversible oxidative modification: a key mechanism of Na+-K+ pump regulation.
2009,
Pubmed
,
Xenbase
Gallogly,
Mechanistic and kinetic details of catalysis of thiol-disulfide exchange by glutaredoxins and potential mechanisms of regulation.
2009,
Pubmed
Gallogly,
Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress.
2007,
Pubmed
Geering,
A role for the beta-subunit in the expression of functional Na+-K+-ATPase in Xenopus oocytes.
1989,
Pubmed
,
Xenbase
Geering,
FXYD proteins: new regulators of Na-K-ATPase.
2006,
Pubmed
Grzmil,
Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells.
2004,
Pubmed
Hansen,
Quantifying the global cellular thiol-disulfide status.
2009,
Pubmed
Hansen,
Increasing the reactivity of an artificial dithiol-disulfide pair through modification of the electrostatic milieu.
2005,
Pubmed
Hashemy,
Oxidation and S-nitrosylation of cysteines in human cytosolic and mitochondrial glutaredoxins: effects on structure and activity.
2007,
Pubmed
Horisberger,
The fourth transmembrane segment of the Na,K-ATPase alpha subunit: a systematic mutagenesis study.
2004,
Pubmed
,
Xenbase
Huang,
Investigation of ouabain-induced anticancer effect in human androgen-independent prostate cancer PC-3 cells.
2004,
Pubmed
Jaunin,
Processing, intracellular transport, and functional expression of endogenous and exogenous alpha-beta 3 Na,K-ATPase complexes in Xenopus oocytes.
1992,
Pubmed
,
Xenbase
Jia,
Hypertrophy, increased ejection fraction, and reduced Na-K-ATPase activity in phospholemman-deficient mice.
2005,
Pubmed
Jones,
Na,K-ATPase from mice lacking the gamma subunit (FXYD2) exhibits altered Na+ affinity and decreased thermal stability.
2005,
Pubmed
Kuster,
Redox-mediated reciprocal regulation of SERCA and Na+-Ca2+ exchanger contributes to sarcoplasmic reticulum Ca2+ depletion in cardiac myocytes.
2010,
Pubmed
Lifshitz,
Purification of the human alpha2 Isoform of Na,K-ATPase expressed in Pichia pastoris. Stabilization by lipids and FXYD1.
2007,
Pubmed
Liochev,
The effects of superoxide dismutase on H2O2 formation.
2007,
Pubmed
Mahmmoud,
Identification of a phospholemman-like protein from shark rectal glands. Evidence for indirect regulation of Na,K-ATPase by protein kinase c via a novel member of the FXYDY family.
2000,
Pubmed
Mahmmoud,
Interaction of FXYD10 (PLMS) with Na,K-ATPase from shark rectal glands. Close proximity of Cys74 of FXYD10 to Cys254 in the a domain of the alpha-subunit revealed by intermolecular thiol cross-linking.
2005,
Pubmed
Mijatovic,
Cardiotonic steroids on the road to anti-cancer therapy.
2007,
Pubmed
Moens,
Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor.
2009,
Pubmed
Morth,
Crystal structure of the sodium-potassium pump.
2007,
Pubmed
Pani,
Redox-based escape mechanism from death: the cancer lesson.
2009,
Pubmed
Presti,
Isoproterenol-induced phosphorylation of a 15-kilodalton sarcolemmal protein in intact myocardium.
1985,
Pubmed
Rasmussen,
Reversible oxidative modification: implications for cardiovascular physiology and pathophysiology.
2010,
Pubmed
Shattock,
Phospholemman: its role in normal cardiac physiology and potential as a druggable target in disease.
2009,
Pubmed
Shinoda,
Crystal structure of the sodium-potassium pump at 2.4 A resolution.
2009,
Pubmed
Starke,
Glutathione-thiyl radical scavenging and transferase properties of human glutaredoxin (thioltransferase). Potential role in redox signal transduction.
2003,
Pubmed
Sweadner,
The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression.
2000,
Pubmed
Teriete,
Structure of the Na,K-ATPase regulatory protein FXYD1 in micelles.
2007,
Pubmed
,
Xenbase
White,
Angiotensin II inhibits the Na+-K+ pump via PKC-dependent activation of NADPH oxidase.
2009,
Pubmed
White,
Activation of cAMP-dependent signaling induces oxidative modification of the cardiac Na+-K+ pump and inhibits its activity.
2010,
Pubmed
White,
Opposing effects of coupled and uncoupled NOS activity on the Na+-K+ pump in cardiac myocytes.
2008,
Pubmed
Winterbourn,
Thiol chemistry and specificity in redox signaling.
2008,
Pubmed
Zhang,
Phospholemman regulates cardiac Na+/Ca2+ exchanger by interacting with the exchanger's proximal linker domain.
2009,
Pubmed
